Virtus ETF Advisers LLC Adc Therapeutics Sa Transaction History

Virtus ETF Advisers LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$5.96 - $14.99 $114,390 - $287,703	-19,193 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$19.29 - $31.51 $10,320 - $16,857	-535 Reduced 2.71%	19,193 $388,000
Q3 2021 Nov 15, 2021	SELL	$20.45 - $30.0 $37,055 - $54,360	-1,812 Reduced 8.41%	19,728 $536,000
Q2 2021 Aug 10, 2021	BUY	$20.38 - $27.04 $260,130 - $345,138	12,764 Added 145.44%	21,540 $524,000
Q1 2021 May 17, 2021	BUY	$22.75 - $34.05 $3,640 - $5,448	160 Added 1.86%	8,776 $214,000
Q4 2020 Feb 12, 2021	BUY	$25.26 - $38.02 $217,640 - $327,580	8,616 New	8,616 $276,000

55.1M

82.7K

31.5K

Ticker ADCT
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,645,296
Market Cap $158M
Description
ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.